ACE2 and diabetes mellitus: This has been attributed to the fact that the patients with diabetes have delayed viral clearance, decreased immunity, and increased angiotensin-converting enzyme 2 (ACE2) expression, leading to an inappropriate response to COVID-19 infection and other secondary infections (41, 61, 62).